Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis

The traditional endpoint for assessing efficacy of chemotherapies for advanced/recurrent gastric cancer is overall survival (OS), but OS requires prolonged follow-up. We investigated whether progression-free survival (PFS) is a valid surrogate for OS. Using individual patient data from the GASTRIC m...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Natl Cancer Inst
Главные авторы: Paoletti, Xavier, Oba, Koji, Bang, Yung-Jue, Bleiberg, Harry, Boku, Narikazu, Bouché, Olivier, Catalano, Paul, Fuse, Nozomu, Michiels, Stefan, Moehler, Markus, Morita, Satoshi, Ohashi, Yasuo, Ohtsu, Atsushi, Roth, Arnaud, Rougier, Philippe, Sakamoto, Junichi, Sargent, Daniel, Sasako, Mitsuru, Shitara, Kohei, Thuss-Patience, Peter, Van Cutsem, Eric, Burzykowski, Tomasz, Buyse, Marc
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2013
Предметы:
Brief Communication
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4994928/
https://ncbi.nlm.nih.gov/pubmed/24108811
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt269
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы